We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

All of this sounds fantastic and could make Lilly an excellent buy, but before you take action, consider this warning: This ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

Mounjaro is the UK brand name of the drug tirzepatide ... in private prescribing of the drug off-label—leading to global stock shortages of semaglutide. Many patients using the semaglutide ...